PDF Infographics

Share

Program Content

Activities

  • Patient Mycophenolate REMS Guide
    Mycophenolate Pregnancy Risks: Patient Information
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 30, 2023

  • Prescriber Guide for Mycophenolate REMS
    Healthcare Professional Communication Guide: Mitigating Pregnancy Risks When Prescribing Mycophenolate Products
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 30, 2023

  • Patient Mycophenolate REMS Guide
    Mycophenolate Pregnancy Risks: Patient Information (in Spanish)
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 30, 2023

  • Patient Mycophenolate REMS Guide
    Mycophenolate Pregnancy Risks: Patient Information (in French)
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 30, 2023

  • Patient Mycophenolate REMS Guide
    Mycophenolate Pregnancy Risks: Patient Information (in Vietnamese)
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 30, 2023

  • Patient Mycophenolate REMS Guide
    Mycophenolate Pregnancy Risks: Patient Information (in Chinese)
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 30, 2023

Faculty

cover img faculity

Cara D. Dolin, MD, MPH

Assistant Professor of Obstetrics/Gynecology and Reproductive Biology
Division of Maternal-Fetal Medicine
Obstetrics and Gynecology Institute
Cleveland Clinic Lener College of Medicine
Case Western Reserve University School of Medicine
Cleveland, Ohio

cover img faculity

Diana Girnita, MD, PhD

Scientific and Medical Consultant
Assistant Prof Rheumatology (Volunteer)
University Of Cincinnati
CEO & Founder Rheumatologist OnCall
Irvine, California

Provided by

ProCE Banner

Provided by Boston University Chobanian & Avedisian School of Medicine, in partnership with Clinical Care Options, LLC

Supporters

This activity is supported by an independent educational grant from the Mycophenolate REMS Group. This activity is intended to be fully compliant with the Mycophenolate REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Mycophenolate REMS Group

Partners

Clinical Care Options, LLC

ProCE Banner